of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
NCT05601336
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
PCO
Interventions
DRUG:
Dapagliflozin 5 MG
DRUG:
Metformin Hydrochloride 1000 MG
DRUG:
Dapagliflozin/Metformin
Sponsor
Beni-Suef University